Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Neuroblastoma × dinutuximab × Clear all

Phase

Status

Completed 8 Recruiting 6 Active not recruiting 6 Unknown 2 Not yet recruiting 2 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neuroblastoma 1

Interventions

Cyclophosphamide 6 Isotretinoin 5 thymoglobulin 4 fludarabine phosphate 4 fludarabine 4 Topotecan 4 Temozolomide 4 Melphalan 4 Irinotecan 4 Etoposide 4 ribociclib 3 aldesleukin 3 Thiotepa 3 Granulocyte Colony-Stimulating Factor 3 Filgrastim 3 Busulfan 3 Bone Marrow Transplantation 3 Antilymphocyte Serum 3 temsirolimus 2 Vincristine 2 Tretinoin 2 TPI-287 2 Stem Cell Transplantation 2 Radiotherapy 2 Peripheral Blood Stem Cell Transplantation 2 Nivolumab 2 Interleukin-2 2 Ifosfamide 2 Granulocyte-Macrophage Colony-Stimulating Factor 2 Flow Cytometry 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02641782 2022-11-04

NB2013-HR

University of Cologne

Phase 2 Terminated

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡